RTP-based AskBio taps former Histogenics exec as new chief business officer
Don Haut, PhD, who previously served as CBO at Sherlock Biosciences and Histogenics, is taking on the role at the clinical-stage adeno-associated virus (AAV) gene therapy company based in RTP.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed